Podcasts about Posner

Nachum Segal presents great Jewish music, the latest news from Israel, interviews with songwriter/pianist Joni Miller, Rabbi Yitzchok Hisiger and Daniel Posner of Athletes for Israel and Morning Chizuk with Rabbi Dovid Goldwasser.

So many people ask me, Sara, how can I get to my daily protein requirement without consuming animal products? After recording this episode with Mege, I thought….think of beans like chicken! I often hear people say, I'm so tired of chicken. Yet, many of us are compelled to find a new and different flavorful recipe to prepare it, right?  So I hope this episode opens your mind to the diverse ways you can add a wide variety of legumes to your meals. We know that when beans, peas, and lentils are combined with other foods, the result is a dish with all of the 9 essential amino acids found in animal products. I'm definitely going to implement some of Mége's time saving and taste tips this week. To learn more visit my website empoweredhealthyliving.org where you can subscribe to my Reset & Launch membership to give you all the tools, strategies, and support you need to transform your life and health. Most of us need support to transform - it's not a question of will power! I've designed this membership program to be a no brainer - easy and flexible because no matter how badly we want different results, without the right support, education, accountability, and structure, it's nearly impossible to get there.  May you be happy and healthy.

Chapters 00:00 Building a Lego City Together03:02 Exploring Interests: Baseball and School05:58 Favorite Books and Learning08:59 Friendship and Family Dynamics11:59 Wishes for the Future 

Behind every “yes” in the toy industry, there's a mountain of “no's,” countless hours of hustle, and more trial and error than most people expect. At one point, he came close to walking away from it all—until a single line from an episode of Bluey reminded him that making games was exactly what he was meant to do.In this episode Making It In The Toy Industry, I'm joined by the incredibly talented Jeremy Posner, owner of Shenanigans Toys and Games, the inventor behind hit games like Beagle or Bagel, Bears in Barrels, and Piggy Piggy. He's been named to the Mojo Nation 100 SIX times, won Game Innovator of the Year at the TAGIEs, and has worked with some of the biggest names in the toy industry like Hasbro, Mattel, and Spin Master. But here's the plot twist: it took Jeremy EIGHT years to meet his royalty goals. And that's after winning major awards and getting meetings with big companies right out the gate.You're gonna hear why just licensing a game doesn't mean you've made it, what really makes a game “sellable” to toy companies, and why most ideas just don't cut it. Jeremy also explained the real deal with royalties or advances, and how long it actually takes to see a check.  He even shared how he trained his brain to be more creative (yes, that's a thing!).Dreaming of creating the next game night hit or just curious what it really takes to make it in toys and games?Hit play and steal a few smart moves for your next big creative leap.Listen for these Important Moments! [00:03:07] - Despite early wins, including a TAGIE award and a background at Big Monster Toys, Jeremy didn't hit his financial goals from game licensing until eight years in. [00:11:17] - After Toy Fair, Jeremy reflects on the silence that often follows a pitch. He explains how learning why you're hearing “no” (and from whom) is key to improving your ideas and not losing steam.[00:23:00] - Around year four, Jeremy stopped “just creating” and started strategically designing evergreens. He audited his creative process, studied the brain, and trained himself to boost creative output daily.[00:33:04] - Jeremy tests tons of game ideas fast by building quick, minimum viable prototypes. He runs super short playtests to see what's worth developing and keep his creativity flowing.[00:40:35] - Near the end of the episode, Jeremy shares his dream of designing fan experiences for sports teams and creating original game shows, proving he's still dreaming big, even after major success in toys and games.Send The Toy Coach Fan Mail! Support the showPopular Masterclass! How To Make & Sell Your Toy IdeasYour Low-Stress, Start-To-Finish Playful Product Launch In 5 Steps >> https://learn.thetoycoach.com/masterclass

What's the difference between a successful freelancer and one who struggles with feast or famine? It's not how good you are at your craft, but how you position yourself to clients. Amy Posner is a seasoned online entrepreneur and business coach who helps digital creative freelancers build breakthrough businesses. Over her 30-year career, she's launched six successful businesses (five of which are still in business today) and mentored thousands of freelancers to success.  Now, Amy focuses on empowering freelancers to grow the business they want by teaching them the skills they need to attract the right clients inside her Complete Breakthrough Freelancer course and on her podcast, Business Badassery. Overcoming Feast or Famine The biggest challenge for freelancers is feast or famine–a windfall of work followed by a period of little to no income. The best way to overcome this is with business systems and processes, so you always have another project in the pipeline. Amy teaches her students skills like writing proposals, selling on calls, and communicating the value they deliver. Many successful freelancers give their clients expert strategic advice, but are selling themselves as order takers–someone who does nothing more than follow orders and create deliverables. If you position yourself as a strategist, you're perceived as much more valuable.  The Difference between an Order Taker and an Expert The primary difference between order takers and experts is that experts deliver an experience, not just deliverables. It starts on the discovery call, when you first connect with the client. High-quality clients want a strategic partner, someone they can trust to give them expert advice and who is interested in getting results. Once you've landed the client, you need to deliver on the experience you've promised. When in doubt, overcommunicate and overdeliver. Again, systems and processes come in handy here. Keep the client in the loop on what's happening, especially for longer projects. Be reliable and do what you say you're going to do. Enjoy this episode with Amy Posner… Soundbytes 12:29-12:43 “I see so many successful freelancers who are giving expert advice, and they're counseling as experts, but they're selling themselves as a creator of deliverables. And you're seen in a very different light.” 18:02-18:21 “The truth is, you don't need a unique perspective. You need a perspective. If a client's going out looking, they don't care that I think the same thing you do. They care what I think. So they're not looking necessarily for originality. They're looking for a stake in the ground, that you believe in something and that you have something to say.”  Quotes “What I noticed was that you could be really great at your craft. And if you didn't have commensurate business skills, you didn't do as well as mediocre craftspeople who had the business side down.” “Nobody gets into business to sell stuff. They get into business because they love doing a thing.”  “I'm a chronic over-deliverer. I like to get invested in people and in getting results.” Links mentioned in this episode: From Our Guest Website: https://amyposner.com/ Connect with Amy Posner on LinkedIn: https://www.linkedin.com/in/amyposnerbusinessgrowthmentor/  Connect with brandiD Download our free guide to learn 16 crucial website updates that attract more leads and convert visitors into clients: https://thebrandid.com/website-tweaks/ Ready to elevate your digital presence with a powerful brand or website? Contact us here: https://thebrandid.com/contact-form/

What happens when farmers become co-creators of innovation—not just end users? In this insightful episode, host Mark Jewell sits down with Margaret Oldham, Vice President of Innovation at AgLaunch, to explore how intentional leadership and farmer-driven solutions are reshaping the future of agriculture.Margaret shares her unique perspective from years in both corporate ag and the startup world, offering actionable insights for operators, visionaries, and anyone navigating change in a dynamic industry. You'll learn how AgLaunch's one-of-a-kind model is connecting startups with real farmers for real-time innovation—and how leaders at every level can grow more intentional, aligned, and impactful.Key Takeaways:

Tariffs have been a hot topic in recent weeks, but this issue has been ongoing. During President Trump's first term, the wine industry was caught flat-footed when, in 2019, the administration put a 25% tariff on still wines from France, Germany, Spain, and the UK (notably, Italy and Portugal were not included) as part of a trade dispute with the EU over subsidies given to Airbus. It was then that my guests – Ben Aneff and Daniel Posner started to organize and get industry leaders together to lobby Congress and try to explain why these tariffs were so harmful to wine. Those tariffs remained in place through 2021, and although there was relief for the last few years, the US Wine Trade Alliance, which was the body that formed out of the initial tariff crisis, continued to exist with Ben at the helm.  In this show, I am honored to have the very busy and very awesome Ben Aneff, a native Texan who now lives in NYC and is the Managing Partner of Tribeca Wine Merchants in New York City, named one of “America's Best Wine Shops” by Food & Wine Magazine, and an “Editor's Favorite” by Wine Spectator. Ben has been actively involved in the fight against wine tariffs – working with all parts of the industry and Congress, and testifying about tariffs' effects at the International Trade Commission.  He is the president of the US Wine Trade Alliance Ben Aneff, President of the U.S. Wine Trade Alliance (USWTA) & Managing Partner of Tribeca Wine Merchants     I also have previous guest and Patron Daniel Posner, owner of Grapes the Wine Company in White Plains, NY. Daniel serves on the Board of Directors of the National Association of Wine Retailers, a national trade organization founded in 2006, for which he served as President from 2011 to 2019. He helped form the USWTA. Daniel Posner of Grapes, the Wine Company & Industry Insider     Full show notes and all back episodes are on Patreon. Join the community today! www.patreon.com/winefornormalpeople _______________________________________________________________   This show is brought to you by my exclusive sponsor, Wine Access – THE place to discover your next favorite bottle. Wine Access has highly allocated wines and incredible values, plus free shipping on orders of $150 or more. You can't go wrong with Wine Access! Join the WFNP/Wine Access wine club and get 6 awesome bottles for just $150 four times a year. That includes shipping! When you become a member, you also get 10% all your purchases on the site. Go to wineaccess.com/normal to sign up!   

On this episode of r-House, your host, Peter Hunt, welcomes Brian Posner, Geothermal Specialist at NOCO Energy Corp.!Together, Peter and Brian discuss a variety of topics, including energy generation and distribution in WNY, energy efficient technology, carbon credit usage, the Climate Leadership & Community Protection Act (CLCRA), developments in renewable/sustainable energy systems, state and federal energy incentives and more.

In this episode of Capital for Good we speak with Michael Posner, the Jerome Kohlberg Professor of Ethics and Finance at NYU's Stern School of Business, director of the school's Center for Business and Human Rights, a long-time leader in the field, luminary thinker, advocate, former State Department Official, and the author of the new book, Conscience Incorporated. We begin with Posner's early interests in international human rights issues, sparked in law school when he was tasked with investigating atrocities in Uganda under Idi Amin. He lays out the principals of early, post-World War II and UN inspired human rights law focused on universality, and the responsibility of governments to promote, protect and enforce human rights. Notably absent from this early framework is the role of business. Posner explains that his interest in the intersection of human rights took shape when he began to observe that large multinational corporations had a critical role to play, particularly when they operated in weak states that lacked the ability to protect human rights. We discuss why companies should care, fundamentally, about human rights on ethical dimensions (“outsourcing might be a smart business strategy, but you can't outsource responsibility if you're the main economic beneficiary,”) and because there are material costs that can arise from irresponsible practices, often reputational crises and/or regulation. We explore the deficiencies of various business frameworks: how and why Milton Friedman's shareholder primacy worldview fails to account for environmental and social externalities and a broader set of stakeholders; how and why ESG conflate environmental and social considerations and emphasize risk rather than meaningful performance on issues like climate change or worker protections. Posner suggests that this moment of backlash against all things ESG, DEI and “woke capitalism” offers us an opportunity to do better. We touch on sometimes complex tensions between climate change and human rights concerns, acknowledging that climate change can only be solved if we transition to a lower carbon economy, with the scale up of renewable energy and the development of technologies like electric vehicles, which in turn rely on things like batteries. We know that today batteries are reliant on inputs like critical minerals, long mined in ways and places rife with human rights challenges, and today often controlled by Chinese companies. China is also the world's largest and lowest cost producer of solar panels, and much of that production occurs in Xinjiang, with forced labor of the Uyghur ethnic minority. Posner discusses a number of ways to better integrate climate and human rights considerations. Before opening the floor to audience questions, we discuss the evolution of technology and human rights issues. When Posner was at the State Department from 2010 to 2012, he had a front tow seat to the Arab Spring and the “Facebook Revolution,” witnessing how activists used social media to fight authoritarianism. Although he says he still believes in the power of technology to open up political discourse, he has become much more concerned about issues of data privacy, surveillance, harmful violent and incendiary content, information and disinformation, and ways in which companies try to shield themselves with first amendment (to which they are not legally subject) to avoid more vigorous content moderation or human rights engagement. We conclude with the role of corporate leaders when it comes to human rights. While Posner notes he is typically conservative about how much executives should speak out on specific issues, he believes strongly that “business leaders need to be attentive and active if there are fundamental threats to our democracy.” This episode of Capital for Good was recorded as part of Social Impact Week 2025, a week of social impact-related events for the Columbia Business School community, organized by the Social Enterprise Club, Green Business Club, Community Impact Club, and LEO Impact Fund. Thanks for Listening! Subscribe to Capital for Good on Apple, Amazon, Google, Spotify, or wherever you get your podcasts. Drop us a line at socialenterprise@gsb.columbia.edu.  Mentioned in this Episode Conscience Incorporated: Pursue Profits While Protecting Human Rights The Fair Labor Association

In today's episode, Dr. Mitchell Posner, Dr. Sarah Shubeck, and Dr. Jelani Williams on the University of Chicago Medicine's new Comprehensive Cancer Center. Scheduled to open in 2027, the new center is a seven-floor, 575,000-square-foot building planned to have 80 private beds and 90 consultation and outpatient rooms. At the moment, the center is anticipated to see 200,000 outpatient visits and 5000 inpatient admissions annually. This would be the city of Chicago's first freestanding cancer pavilion.How will we ensure that this new center prioritizes the community's needs? In Chicago's South Side, cancer death rates are twice the national average, and cancer is also the second-leading cause of death on the South Side behind heart disease. In this conversation, you'll hear about the center's development, what patients can expect, and most importantly, the Department of Surgery's commitment to ensure the cancer center supports those who are most vulnerable. Dr. Mitchell Posner is the Thomas D. Jones Distinguished Service Professor of Surgery, Chief of the Section of General Surgery, and the Chief Clinical Officer of the University of Chicago Medicine Comprehensive Cancer Center. From clinical trials for cancer treatment to his more than 250 articles, abstracts, and book chapters, Dr. Posner is a leading authority in the management of upper gastrointestinal cancers. He is frequently voted among the country's best doctors. He is the past president of the Society of Surgical Oncology. He is deputy editor of the Annals of Surgical Oncology and section editor for the gastrointestinal cancer section of the journal Cancer. He served as chairman of the Gastrointestinal Committee of the American College of Surgeons Oncology Group (ACOSOG).Dr. Sarah Shubeck is an Assistant Professor in the Department of General Surgery. She is a Breast Surgical oncologist specializing in breast surgery, cancer, and benign disease treatment. In addition to her clinical practice, Dr. Shubeck's research has been published in many journals including Cancer, JAMA Surgery, and Annals of Surgical Oncology.Dr. Jelani Williams is a 5th-year general surgery resident at the University of Chicago. He is an aspiring surgical oncologist and attended the Eastern Virginia Medical School. He has published research on predictive models and surgery for metastatic pancreatic neuroendocrine tumors as well as the use of machine learning to distinguish benign and malignant thyroid nodules amongst other topics. Deep Cuts: Exploring Equity in Surgery comes to you from the Department of Surgery at the University of Chicago, which is located on Ojibwe, Odawa and Potawatomi land.Our executive producer is Tony Liu. Our senior producers are Alia Abiad, Caroline Montag, and Chuka Onuh. Our production team includes Megan Teramoto, Ria Sood, Ishaan Kumar, and Daniel Correa Bucio. Our senior editor and production coordinator is Nihar Rama. Our editorial team also includes Beryl Zhou and Julianna Kenny-Serrano. The intro song you hear at the beginning of our show is “Love, Money Part 2” from Chicago's own Sen Morimoto off of Sooper Records. Our cover art is from Leia Chen.A special thanks this week to Dr. Jeffrey Matthews — for his leadership, vision, and commitment to caring for the most vulnerable in our communities. Let us know — what have you most enjoyed about our podcast. Where do you see room for improvement? You can reach out to us on Instagram @deepcutssurgery. Find out more about our work at deepcuts.surgery.uchicago.edu.

For decades, there have been numerous conspiracy theories related to the assassination of President John F. Kennedy. President Trump's recent release of thousands of pages of files was intended to shed light on the murder. FOX News Rundown host Lisa Brady recently spoke with Gerald Posner, an American investigative journalist and the author of “Case Closed: Lee Harvey Oswald and the Assassination of JFK.” Posner has investigated the assassination and the conspiracy theories for decades. He went through some of the new information released and explained why nothing changed his belief that Lee Harvey Oswald acted alone when he shot the President. We often must cut interviews short during the week, but we thought you might like to hear the full interview. Today on Fox News Rundown Extra, we will share our entire interview with author and journalist Gerald Posner. We will get even more of his take on the JFK assassination and why he thinks some of the most popular conspiracy theories cannot be true. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Collaboration is the cornerstone of a musicians' creativity and career. This is especially true in media composing. And here to talk with me about it today are my guests Ari Posner and Joel Schwartz. They worked together composing the score to the acclaimed drama series “Sullivan's Crossing” whose 2nd season premiered in the US in October 2024 on the CW, and kicks off its 3rd season on Canada's CTV in the spring of 2025.

For decades, there have been numerous conspiracy theories related to the assassination of President John F. Kennedy. President Trump's recent release of thousands of pages of files was intended to shed light on the murder. FOX News Rundown host Lisa Brady recently spoke with Gerald Posner, an American investigative journalist and the author of “Case Closed: Lee Harvey Oswald and the Assassination of JFK.” Posner has investigated the assassination and the conspiracy theories for decades. He went through some of the new information released and explained why nothing changed his belief that Lee Harvey Oswald acted alone when he shot the President. We often must cut interviews short during the week, but we thought you might like to hear the full interview. Today on Fox News Rundown Extra, we will share our entire interview with author and journalist Gerald Posner. We will get even more of his take on the JFK assassination and why he thinks some of the most popular conspiracy theories cannot be true. Learn more about your ad choices. Visit podcastchoices.com/adchoices

For decades, there have been numerous conspiracy theories related to the assassination of President John F. Kennedy. President Trump's recent release of thousands of pages of files was intended to shed light on the murder. FOX News Rundown host Lisa Brady recently spoke with Gerald Posner, an American investigative journalist and the author of “Case Closed: Lee Harvey Oswald and the Assassination of JFK.” Posner has investigated the assassination and the conspiracy theories for decades. He went through some of the new information released and explained why nothing changed his belief that Lee Harvey Oswald acted alone when he shot the President. We often must cut interviews short during the week, but we thought you might like to hear the full interview. Today on Fox News Rundown Extra, we will share our entire interview with author and journalist Gerald Posner. We will get even more of his take on the JFK assassination and why he thinks some of the most popular conspiracy theories cannot be true. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Nachum Segal presents Daniel Posner of Athletes for Israel, The Jewish Link's Moshe Kinderlehrer and Elizabeth Kratz, cookbook author Rivky Kleiman, great Jewish music, the latest news from Israel and Morning Chizuk with Rabbi Dovid Goldwasser,

This week on The Geek in Review, we welcome Zach Posner, co-founder and managing director of The Legal Tech Fund. Zach brings a dynamic mix of first‐hand experience and visionary insight into the world of legal tech investments. The conversation kicks off with a discussion of recent high-profile funding rounds—such as Harvey's $300 million raise—and the growing influx of generalist VC interest in the legal space. This episode sets the stage by framing legal tech as a rapidly evolving market that's finally getting the spotlight it deserves.Decoding Funding Dynamics and Early-Stage ChallengesA key portion of the discussion centers on the inefficiencies of early-stage funding in the legal tech arena. Zach explains that, unlike public markets with readily available metrics, early-stage investments rely heavily on personal relationships and entrepreneurial trust. He highlights how the lack of data and public comparables makes each handshake a significant moment of risk and opportunity. The dialogue provides listeners with an insider's perspective on why leadership credibility and entrepreneurial vision are often more critical than raw business metrics in legal tech startups.Community Building and Collaborative InnovationAnother major theme in the conversation is the importance of community and collaboration. Zach underscores that the Legal Tech Fund isn't just about injecting capital—it's about cultivating an ecosystem where startups, law firms, and legal departments work hand-in-hand. The fund's unique approach of engaging with 65 different portfolio companies daily has fostered a network that benefits from shared insights and strategic partnerships. This community-first approach, according to Zach, is instrumental in driving both innovation and seamless product integration for legal professionals.Embracing AI and User-Centric SolutionsThe conversation takes a forward-looking turn as Zach discusses how artificial intelligence is revolutionizing legal workflows. While many legal tech innovations focus on enhancing efficiency, he stresses that creating an exceptional user experience is paramount. Zach notes that the rapidly evolving AI landscape demands that legal tech startups not only keep pace with technological advancements but also prioritize intuitive design and seamless integration. This approach helps ensure that even as technology becomes more powerful, it remains accessible and directly relevant to the end user.Looking Ahead: The Future of Legal TechWrapping up the episode, Zach offers a crystal ball view of the future, predicting that the next few years will see even more dramatic changes in legal tech. From AI-driven workflow automation to innovative partnerships between law firms and startups, the sector is poised for transformative growth. He encourages legal professionals to experiment, learn continuously, and stay curious about emerging technologies. For listeners eager to explore further, Zach directs them to legaltech.com and TLTFsummit.com, promising more insights and upcoming announcements. This episode is a must-listen for anyone interested in the convergence of law, technology, and innovation.Listen on mobile platforms:  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Blue Sky: ⁠⁠@geeklawblog.com⁠⁠ ⁠⁠@marlgeb⁠⁠⁠⁠⁠⁠⁠Email: geekinreviewpodcast@gmail.comMusic: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Jerry David DeCicca⁠⁠⁠⁠⁠⁠⁠⁠⁠ Transcript

Treat your business like a business!  If you are a freelancer, VA or Social Media Marketer, you also need to show up online!  Fill up your pipeline and create a business that will help you get out of the feast and famine cycle. We have an amazing freelancer mentor, Amy Posner with 30 years of experience to share with you!  This is part of our new campaign - Around the World in 90 days - your ticket to good content marketing!  Welcome aboard flight CQM222, I am your pilot, Mariah - you have your ticket to good content marketing in hand.  While on this flight the flight attendants will be here to assist you to get off the content creation hamster wheel and onto a new way of marketing to help you live a more freedom-based lifestyle.  Each week you will be given a new stamp in your passport and by the end of the 90 days you will be on your way to explore the world of Content Marketing as a solo traveller.  This is week eleven - get ready, it is going to be a wild ride!  If you LOVED this part of your trip (the episode), make sure you share this on your Instagram stories and tag us @contentqueenmariah and @amyrposner.  ⁠⁠⁠GET ACCESS TO OUR FREE AUDIO GUIDE - CONTENT STRATEGY IN YOUR EARS KEY EPISODE TAKEAWAYS

Ever wanted to sit down with Copywriter Legend, Amy Posner, and hear firsthand about the top few factors that influenced her successful career? Well now's your chance to pull up a seat and dig into Amy's background, how she got started in business, copywriting, and then climbed to the top.   Along the way Amy is sharing her thoughts on pricing, positioning yourself as a strategist, not an order taker, and what she thinks copywriters need to do to stand out in the world of AI today. Hit ‘Play' now and listen to this special What Made The Difference episode of the Freedom Found Podcast.   Tune in To Learn: How Amy accidentally became a serial business owner The key ingredients copywriters need to be seen as a strategist by their clients Why some copywriters charge $3k and others $30k for the “same” work Amy's top success influencers and the importance mentorship played in her career   **********   Like this show? Write a 5-star review — even just one sentence helps us bring you more content each week.    Resources & Follow: ***Get the FREE Private Podcast → The Copywriter's Guide: How to Make $20k Months from your Course, Templates or Program: https://krystlechurch.com/privatepodcast  → The KC Website: https://krystlechurch.com/  → Freedom Found Collective Mastermind: https://krystlechurch.com/freedom-found-collective  → Get *Probably* The Best Copywriting Newsletter You'll Ever Read: https://krystlechurch.com/copy-classroom  → Follow on IG: https://www.instagram.com/krystle.church    → Connect with Amy Posner at: http://www.amyposner.com → Follow Amy Posner on LinkedIn: https://www.linkedin.com/in/amyposnerbusinessgrowthmentor/

The Rich Zeoli Show- Full Episode (01/22/2025): 3:05pm- Speaking from the Roosevelt Room of the White House on Tuesday night, President Donald Trump held a press conference announcing OpenAI, Oracle, SoftBank, and several other companies will invest $500 billion to build the nation's artificial intelligence infrastructure. While some are vocally expressing fear that A.I. could lead to a societal downfall, Rich expresses optimism. He notes that its necessary for the U.S. to drive advancements in the critical technological field—as the alternative would be to allow geopolitical rival China to dominate the sphere which would have catastrophic implications for national security. 3:40pm- Brianna Lyman—Elections Correspondent for The Federalist—joins The Rich Zeoli Show to discuss her latest article, “Media's Regurgitation of Baseless Hegseth Allegations Prove They Learned Nothing Post-Election.” You can read the full article here: https://thefederalist.com/2025/01/22/medias-regurgitation-of-baseless-hegseth-allegations-prove-they-learned-nothing-post-election/ 4:05pm- Rich is still recovering from his foot surgery—and decides to take his medicine live on air…how exciting! 4:10pm- Philadelphia Mayor Cherelle Parker led a crowd in an Eagles chant following the team's big win against the Los Angeles Rams—but she somehow misspelled “Eagles.” 4:20pm- In a press conference, Canadian Prime Minister Justin Trudeau—who is the son of former Canadian Prime Minister Pierre Trudeau and definitely not former Cuban dictator Fidel Castro—warned President Donald Trump against imposing tariffs on Canada. 4:30pm- On Wednesday, President Donald Trump picked New Jersey State Senator Douglas J. Steinhardt to serve as acting U.S. Attorney for New Jersey. 4:40pm- In a series of Executive Orders signed on Monday night from the Oval Office, President Donald Trump mandated employees of the federal government work in-person, withdrew the nation from the Paris Climate Agreement, withdrew the nation from the World Health Organization (WHO) citing their willingness to cover-up China's COVID-19 transgressions, delayed enforcement of a national ban of TikTok, recognized two genders—male and female, pardoned 1,500 Americans arrested for their actions on January 6th, 2021, expanded domestic energy production, shut down the U.S. Southern border, and guaranteed free speech on social media. Trump also fulfilled a long-term campaign pledge to focus on meritocracy and pivot away from the prioritization of far-left policies like diversity, equity, and inclusion (D.E.I.) within the federal government. 4:45pm- Trump Delivers on His Promise to Dismantle DEI: Jason Riley, opinion columnist for The Wall Street Journal, writes: “It's no surprise that increasing the salience of race, and favoring some groups over others, can only harm the social cohesion necessary to sustain a multiethnic society. A Gallup poll released last week found that a plurality of Americans (39%) said that race relations had worsened under Mr. Biden, versus just 24% who said they had improved.” You can read t full article here: https://www.wsj.com/opinion/trump-delivers-on-his-promise-to-dismantle-dei-race-ethnicity-policy-f5847d0a 5:00pm- Gerald Posner—Award-Winning Investigative Journalist & Author of the book “Pharma: Greed, Lies, and the Poisoning of America”—joins The Rich Zeoli Show to discuss his latest article, “Hitler, Musk, and the Art of the Smear.” PLUS, Rich and Posner debate the Kennedy assassination. Will President Donald Trump release the JFK files, as he pledged to do on the campaign trail? You can read the full article here: https://www.justthefacts.media/p/hitler-musk-and-the-art-of-the-smear 5:20pm- Appearing on Fox News with Lawrence Jones, Trump Administration Border Czar Tom Homan revealed that since Donald Trump took office on Monday I.C.E. has arrested over 100 dangerous criminals who entered the country illegally. 5:25pm- While speaking to reporters outside o ...

The Rich Zeoli Show- Hour 3: 5:00pm- Gerald Posner—Award-Winning Investigative Journalist & Author of the book “Pharma: Greed, Lies, and the Poisoning of America”—joins The Rich Zeoli Show to discuss his latest article, “Hitler, Musk, and the Art of the Smear.” PLUS, Rich and Posner debate the Kennedy assassination. Will President Donald Trump release the JFK files, as he pledged to do on the campaign trail? You can read the full article here: https://www.justthefacts.media/p/hitler-musk-and-the-art-of-the-smear 5:20pm- Appearing on Fox News with Lawrence Jones, Trump Administration Border Czar Tom Homan revealed that since Donald Trump took office on Monday I.C.E. has arrested over 100 dangerous criminals who entered the country illegally. 5:25pm- While speaking to reporters outside of the White House, Press Secretary Karoline Leavitt confirmed that 1,500 U.S. troops will be sent to the Southern border to protect the country's sovereignty. In an executive order signed on Monday night, the Trump Administration classified unlawful border crossings as an “invasion” and designated drug cartels as “foreign terrorist organizations” which should allow the administration to circumvent the Posse Comitatus Act. 5:30pm- Daniel Cochrane—Senior Research Associate for the Tech Policy Center at The Heritage Foundation—joins The Rich Zeoli Show to discuss President Donald Trump's announcement that several private companies have announced a $500 billion investment in the development of national artificial intelligence infrastructure. Is the U.S. in an A.I. race with China? 5:50pm- Meta CEO Mark Zuckerberg got caught checking out Lauren Sanchez—Jeff Bezos's fiancé—during Donald Trump's presidential inauguration.

On episode 168 of the Sofa Kingdom Podcast Margo returns to talk tiktok And khabib on a plane.   Guest: Margo Posner #Jitzchickz   Find more Sofa Kingdom Podcast at SofaKingdomOfc on instagram https://www.instagram.com/sofakingdomofc/ Audio podcast is on all major podcast platforms just search "Sofa Kingdom Podcast"   General topics this episode tiktok ban, khabib nurmagomedov kicked off plane, ufc 311, when do you get called captain,

The public often imagines corporations as self-contained actors that provide a set of goods and services to consumers. Underpinning this image have been ideas of ownership, rights to capital and intellectual property, and corporate responsibility to stakeholders including consumers, workers, and shareholders. But what if almost everything we are told about the essence of the firm is wrong? So writes Sir John Kay, a British economist, corporate director, and longstanding fellow of St John's College (Oxford) in his new book, The Corporation in the 21st Century.The book revolves around contrasts between historical conceptions of corporations, capitalism, and contemporary practices. Kay writes, “A central thesis of [this] book is that business has evolved, but the language that is widely used to describe business has not.” In the 19th and 20th centuries, firms could be defined in terms of their control over material forms of productive capital (factories, steel foundries, railways, etc.) Socioeconomic critiques of capitalism, most prominently from Karl Marx, often centered on firms' control of the means of production. Kay contends that firms today access productive capital as a service. For example, Amazon does not own its warehouses but rents them from another firm. Kay writes that today's corporations and capitalism “[have] very little to do with ‘capital' and nothing whatsoever to do with any struggle between capitalists and workers to control the means of production.”Kay joins Luigi and Bethany to discuss the implications of this evolution in firms' relation to capital: Why is it important to capitalism that its biggest firms no longer own their means of production? Why does the language used to describe this matter? What do Apple's manufacturing facilities, Amazon's warehouses, and TikTok's algorithms tell us about our notions of business ownership? How have these changes to capitalism redefined the struggle between the owners of capital, managers, workers, and consumers? In the process, Kay, Luigi, and Bethany explore the failures of capitalism and imagine what could and should be the purpose of the 21st-century corporation.Show Notes:Read an excerpt from the book (published by Yale University Press) on ProMarketIn Bethany and Luigi's closing discussion of Kay's book, Luigi cites several articles he has published on the topic, which we have linked below for the listener's reference. In this past scholarship, Luigi studies how a firm and its operations often intertwine with other firms to form an ecosystem, and it is only through this ecosystem that value is created. Apple and Foxconn provide one example. Legally, they are distinct firms, yet Luigi contends they can be understood as elements of an ecosystem that creates value. Hence, it is sometimes productive to think beyond legal boundaries to consider how multiple firms may compose such a value-creating ecosystem in practice. Within the Apple/Foxconn ecosystem, Apple has a significant influence in dictating terms for Foxconn. Further, if Apple has such dominating power over its suppliers, then Apple could be said to have market power that raises antitrust concerns, which are less obvious if we take the legal boundaries of firms as the correct method of conceptualizing them.Zingales, L., 2000. In search of new foundations. The Journal of Finance, 55(4), pp.1623-1653.Rajan, R.G. and Zingales, L., 1998. Power in a Theory of the Firm. The Quarterly Journal of Economics, 113(2), pp.387-432.Rajan, R.G. and Zingales, L., 2001. The firm as a dedicated hierarchy: A theory of the origins and growth of firms. The Quarterly Journal of Economics, 116(3), pp.805-851.Zingales, L. (1998) Corporate Governance. In: Newman, P., Ed., The New Palgrave Dictionary of Economics and the Law, Palgrave Macmillan, London.Lancieri, F., Posner, E.A. and Zingales, L., 2023. The Political Economy of the Decline of Antitrust Enforcement in the United States. Antitrust Law Journal, 85(2), pp.441-519.

Welcome to the 65th episode of Ecommerce Toolbox: Expert Perspectives – this time, host Kailin Noivo sits down with Jenna Flateman Posner, Founder of Chief Digital Agency, for an in-depth discussion on how AI is reshaping retail. Jenna shares her journey from retail tech to leading digital transformations for major brands. Jenna discusses actionable strategies for aligning technology with consumer needs, from optimizing fraud detection to enabling conversational search. Learn how AI can simplify operations, enhance customer service, and drive profitability while keeping your brand competitive in today's digital-first landscape.

In this episode of Simulcast, Vic Brazil is joined by Vicki LeBlanc and Glenn Posner to discuss their recent article "More Than a Feeling: Emotional Regulation Strategies for Simulation-Based Education" published in Advances in Simulation.   The conversation delves into the importance of recognizing and addressing emotions in simulation-based learning environments. Vicki and Glenn share insights on why emotions are often seen as taboo or difficult to manage in simulation, despite being a natural part of clinical practice (and everyday life!). They explain how emotions impact cognitive processes like attention, judgment and memory, and why ignoring them can hinder learning objectives.  We explore practical strategies for identifying emotional cues, assessing whether emotions are helpful or hindering, and employing implicit or explicit regulation techniques. We emphasize the need to normalize emotional responses and view them as valuable data, rather than something to be avoided.  The article aims to provide simulation educators with a comprehensive framework for understanding and responding to the emotional aspects of simulation-based learning. It challenges the notion that simulation should be a purely rational endeavour, underscoring the vital role emotions play in preparing healthcare learners for the realities of clinical practice.  Happy listening! 

Inspiring a new edge in creativity and innovation at Google's Creative Works, director Abigail Posner is a recognized industry maven who inspires change in the world around her. As a leader, author, public speaker, host, and corporate executive, this Harvard-educated strategist sparks rethinking and action wherever she goes.Join us on a journey exploring connection, digital culture, and the beauty surrounding us, through her unique humanistic lens of what matters most today.

Anna and Raven chat with Carolyn Posner, Director, Executive Communications of the Consumer Technology Association to learn more about the CES, a tradeshow that showcases new tech that is coming out!  Photo Credit: Getty Images

Join us as we sit down with Zach Posner, founder of The Legal Tech Fund (TLTF) and the visionary behind the TLTF Summit, to unpack the unprecedented surge of innovation, talent, and investment reshaping the legal industry. From the rise of generative AI to law firms embracing venture capital mindsets, Zach offers insider insights into where legal tech is headed and why now is the time to lean in. What You'll Learn in This Episode: The $1 Billion Day in Legal Tech: How a single day in 2024 redefined the investment landscape. Generative AI's Legal Impact: The explosion of generative AI startups and what it means for law firms and legal operations. Legal Tech's Talent Revolution: Why top talent from Google, Facebook, and Netflix is flocking to legal tech startups. The Pyramid of Legal Tech Growth: Breaking down the lifecycle of startups—from early-stage experiments to scalable success. Law Firms as VCs: How firms are experimenting with technology and funding innovation to future-proof their practices. Retention Through Innovation: Why firms investing in cutting-edge tech are winning the war for talent. Key Highlights: (1:08) ChatGPT's historic debut and its role in igniting a generative AI gold rush. (3:28) The 239% growth in generative AI startups in just eight months—what's driving this explosive trend. (12:13) Why law firms with innovation funds are attracting and retaining top talent. (14:17) The Rubik's Cube analogy: How law firms are experimenting with tech to find the perfect fit. (15:03) The importance of focusing tech adoption in high-impact practice areas for maximum ROI. Connect with Zach Posner: LinkedIn: Zach Posner Subscribe and Share: Don't miss an episode—find us on Apple Podcasts, Spotify, or your favorite platform. If you're ready to take your career from now to next, remember: never eat alone.

What does it take to build a successful legal tech startup?   In this Best of 2024 episode, we revisit our conversation with Zach Posner, co-founder of the LegalTech Fund, an investment fund focused on supporting innovative legal technology companies. Zach's unique perspective on legal tech investing is rooted in his broad experience, including building an education tech company acquired by McGraw Hill. During our conversation, he shares valuable insights into what makes startups thrive. From the importance of transparent investor updates to fostering frequent, meaningful customer interactions that guide product development.   We also explore the LegalTech Fund's investment focus: Tools leveraging contracting data for business insights Tech solutions expanding access to legal services Whether you're an entrepreneur, an investor, or simply interested in the evolution of legal tech, this episode is full of practical advice and inspiring insights. Episode Credits Editing and Production: Grant Blackstock Theme Music: Home Base (Instrumental Version) by TA2MI   Want to keep up to date about new episodes? Technically Legal Update List. Want to learn more about Percipient (percipient.co)? Follow Chad on Linkedin: Chad Main | LinkedIn Follow the podcast on LinkedIn: Technically Legal | LinkedIn Follow the podcast on Instagram: Technically Legal | Instagram Follow the podcast on X: Technically Legal | X

Robert Posner shares his story of repentance and restoration and discusses a difficult subject for Christians and the Church. Robert's experience led him to start 24:16 Ministries. Find more at https://www.2416ministries.org. #NAFWB #BetterTogether

"The more inflamed you are, the faster you age."In this episode:The perimenopause, inflammation and aging connection Digestive enzymes to combat inflammation! Collagen and coffee - don't do it!Arnica for injury and inflammation What is NAD+ and why is it important? Semaglutides / GLP-1s and weight loss GLP-1s for managing menopause symptoms

In this insightful episode of Don't Waste the Chaos, we sit down with John Thomas, a seasoned leader and published author with over 25 years of experience in higher education, government administration, nonprofits, and organizational consulting. Currently a Consultant with the Organization Development team at Washington University in St. Louis, John has a remarkable track record in leadership coaching, team building, and employee engagement. From reducing vacancy fill times to transforming workplace cultures, John's leadership journey is full of practical lessons and inspiring stories. We explore his leadership philosophy, the role of emotional intelligence, and actionable strategies for leading through uncertainty. Plus, John introduces us to the key concepts of his book, Nobility, offering insights that you can start applying today. Whether you're leading a team, growing a business, or navigating personal growth, this episode is a goldmine of actionable wisdom. Tune in to Hear: The core principles of leadership every business owner should know How emotional intelligence can transform the way you lead your team Strategies for leading teams through uncertainty and change The role mentorship plays in developing strong, effective leaders Key takeaways from John's book, Nobility, and how they can help you lead with integrity and purpose Resources & Books Referenced [in Kerri's Amazon store]: Connect with John Thomas on LinkedIn https://www.linkedin.com/in/johnthomas2/ or on X @Coach_Tee Get your copy of Nobility by John Thomas: https://amzn.to/3YZU8eJ The Leadership Challenge by Kouzes & Posner: https://amzn.to/4fIw8T3 Join our weekly newsletter: HR and Operations insights for business professionals: https://www.saltandlightadvisors.com/contact Women looking to expand professionally and personally: https://www.saltandlightforwomen.com/contact Connect on IG: https://www.instagram.com/saltandlightadvisors https://www.instagram.com/saltandlightforwomen https://www.instagram.com/dontwastethechaos Check out Don't Waste the Chaos on YouTube: https://youtu.be/Ikyi0-jxcAI?si=7eR8I6YZll-lYI7i Visit our website: www.dontwastethechaos.com Don't Waste the Chaos, Embrace It!

Roben Graziadei, MA is the founder and president of Net Result$, LLC, and is a highly successful leadership consultant and speaker. In 2015 she branded Instinctology® and authored Instinctology®, A Leadership Method to Turn GUT Instincts into Concrete Action. Roben began her career as a Senior Consultant with FranklinCovey and was also a Principal of the The Tom Peters Group (Tom Peters, author of In Search of Excellence) where she taught The Leadership Challenge (by Kouzes and Posner) workshops.  Having consulted with the C-Suite of many Fortune 500 companies and higher education institutions, Roben then trained over 500K people from the mailroom to the boardroom, helping to develop strong leaders and work units at all levels.  In this episode, she shares valuable insights and actionable advice that can be of great benefit to leaders at every level.

When Zach Posner was last on this podcast, it was 2021 and he was less than a year into having cofounded The LegalTech Fund, the first venture capital firm to be laser-focused on law and legal technology. Since then, his firm, of which he is managing director, has gone on to build up a portfolio of more than 60 legal tech companies in which it invests.  His firm has also launched his own conference, the TLTF Summit, which will convene for the third straight year starting Dec. 4 in Key Biscayne, Fla. After attending the first summit, LawNext host Bob Ambrogi wrote in his review, “It was a superlative conference – one like no other conference in legal tech.” We've been wanting to get Zach back on this podcast for an update, and as it happens, he was in attendance at the recent Clio Cloud Conference, where we were set up with my mics and recording equipment. So Zach and Bob sat down for this impromptu conversation about his firm, his conference, and his thoughts on the legal tech landscape.    Thank You To Our Sponsors This episode of LawNext is generously made possible by our sponsors. We appreciate their support and hope you will check them out. Paradigm, home to the practice management platforms PracticePanther, Bill4Time, MerusCase and LollyLaw; the e-payments platform Headnote; and the legal accounting software TrustBooks. Briefpoint, eliminating routine discovery response and request drafting tasks so you can focus on drafting what matters (or just make it home for dinner).   If you enjoy listening to LawNext, please leave us a review wherever you listen to podcasts.  

In today's episode, I'm thrilled to chat with Amy Posner, a true trailblazer in the world of online business and coaching. Amy has built six thriving businesses (five are still going strong!) and empowered thousands of freelancers to find their footing and flourish. She shares insights from her course, Complete Breakthrough Freelancer, and her experience as co-host of Business Badassery.Find out why she says it's not them, it's you….what you are doing that is keeping you from achieving your dreams.In our chat, we get into the good stuff: • How to attract and keep ideal clients by building genuine relationships • How to bring business skills up to the level of your creative ones (the real key to six figures and beyond!) • Creating value for clients before they even see a price tag • Seeing your clients as partners, so they know they're in good hands • Moving beyond a six-figure income as the ultimate goal to find what truly drives your successAmy and I are “kindred spirits” and clicked instantly, and I couldn't help but wish she lived closer so we could keep these conversations going!Enjoy this conversation filled with so many tips for being super successful doing what you loveAnd reach out to her here to ask a question or learn about her course and podcast. alexis@publicityxchristina.com 360-480-3079https://amyposner.com/Connect with Photography Business Coach Luci Dumas: Website Email: luci@lucidumas.comInstagram FacebookYouTube

00:00 Introduction to Angela Hood and ThisWay Global03:11 Angela's Entrepreneurial Background and Early Lessons05:51 Navigating Gender Bias in Construction and Tech09:12 Transitioning from Construction to Technology12:00 The Mission Behind ThisWay Global14:58 The Importance of Accelerators in Startups18:01 Understanding AI and Bias in Recruitment20:57 Candidate Bias and Self-Disqualification23:58 The Impact of Brand Perception on Job Applications26:57 Leveraging AI for Recruitment Solutions29:54 Future Innovations and the Role of AI33:02 The Importance of Critical Thinking in the Workforce35:57 Defining Success and Personal Growth38:53 Final Thoughts and Advice from Angela Hood

Vic is joined by renowned musician Mike Posner, who is celebrated for his chart-topping hits like "Cooler Than Me" and "I Took a Pill in Ibiza." In this episode, Posner shares his journey from shy basement musician to international pop star, giving us an intimate look at his personal and professional transformation. He opens up about how fame and success weren't all he expected, and how that realization inspired him to begin his own spiritual growth journey. You'll learn the true meaning behind his hit song, “I Took A Pill In Ibiza,” and the figures that inspired him to heal like Vic's fav Eckhart Tolle and Tony Robbins. This episode is a must-listen for anyone seeking inspiration on resilience, honesty, and a continuous search for self-improvement. Instagram: @mikeposnerListen to Mike Posner on Spotify: https://open.spotify.com/artist/2KsP6tYLJlTBvSUxnwlVWaSponsors:LMNT: Get your free LMNT Sample Pack with any purchase at drinklmnt.com/REALPODKITS Eyewear: Producer Christiana loves these!!! www.kits.com code REALPOD for 20% off!Manukora: Head to MANUKORA.com/REALPOD to get $25 off the Starter Kit.AG1: www.drinkag1.com/realpodProduced by Dear MediaThis episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct, or indirect financial interest in products, or services referred to in this episode.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Learn all about how to repair your nervous system naturally with yoga therapist Rachel Posner. Discover the connection between your nervous system and autoimmune and your immune system. Learn what causes stop, fight and flight syndrome and many other aspects of how your nervous system and immune system are connected. Rachel Posner, C-IAYT, E-RYT, is a yoga therapist and mindfulness coach helping people reduce stress, build resilience and thrive. She offers individual yoga therapy sessions, mindfulness courses, yoga memberships and retreats. Her work is informed by the intersection of mindfulness, neuroscience and psychology and her teachings integrate best practices for the mind, body and brain. Rachel has been in the wellness field for 24 years and is driven by a deep desire to help people feel calm, connected and engaged in their lives. You can learn more at www.rachelposner.com   https://www.rachelposner.com/ Free Practice: Take 5 to Relax and Reset October Meditation Series Free Trial: Your Yoga: A Virtual Community   Website for this podcast My Youtube Channel https://www.facebook.com/groups/1274175526859581- Self Care Facebook Group Free Autoimmune Healing Ebook- http://annalaurabrown.com/ebook Free Webinar- Avoid these 10 common autoimmune healing mistakes. https://expertise.tv/webinar/empowering-women-transform-your-health-journey-by-avoiding-these-10-common-autoimmune-mistakes-2024-02-29/landing/19523

Jump into the wormhole for another edition of The Ryan Show FM radio program! Join #ryanverneuille for the best of this week's content hand wrapped and delivered for your radio experience! This weeks special guests include NYC real estate mogul Jonathan Normolle, the King of Las Vegas real estate Mark Anthony Posner, viral emcee HG Rambo, Extreme Exposure Radio owner Top Dre and behavioral scientist Dr. Natanya Wachtel! This week's program is brought to you by @laliaisoncleaning #theryanshow #hamptonsdave #mrcheeks #topdre #natanyawachtel #hgrambo #markanthonyposner #posnerland #jonathannormolle 

Many autoimmune neuromuscular disorders are reversible with prompt diagnosis and early treatment. Understanding the potential utility and limitations of antibody testing in each clinical setting is critical for practicing neurologists. In this episode, Teshamae Monteith, MD, FAAN speaks with Divyanshu Dubey, MD, FAAN, author of the article “Autoimmune Neuromuscular Disorders Associated With Neural Antibodies,” in the Continuum® August 2024 Autoimmune Neurology issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. Dubey is an associate professor in the departments of neurology and laboratory medicine and pathology at the Mayo Clinic in Rochester, Minnesota. Additional Resources Read the article: Autoimmune Neuromuscular Disorders Associated With Neural Antibodies Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Guest: @Div_Dubey Transcript Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, which features conversations with Continuum's guest editors and authors who are the leading experts in their fields. Subscribers to the Continuum journal can read the full article or listen to verbatim recordings of the article and have access to exclusive interviews not featured on the podcast. Please visit the link in the episode notes for more information on the article, subscribing to the journal, and how to get CME.   Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. Today, I'm interviewing Dr Divyanshu Dubey about his article on autoimmune neuromuscular disorders associated with neural autoantibodies, which is part of the August 2024 Continuum issue on autoimmune neurology. Welcome to the podcast. How are you?   Dr Dubey: Hi, Dr Monteith. Thank you for inviting me to be a part of this podcast. I'm doing well.   Dr Monteith: Well, why don't you introduce yourself to the audience? And, call me Tesha.   Dr Dubey: I'm Divyanshu Dubey (please, call me Div). I'm one of the autoimmune neurology consultants here at Mayo Clinic Rochester. I'm an Associate Professor of neurology, as well as lab medicine and pathology. My responsibilities here are split - partly seeing patients (primarily patients with autoimmune disorders, including neuromuscular disorders), and then 50% of my time (or, actually, more than 50%), I spend in the lab, either doing research on these autoimmune disorders or reporting antibodies in a clinical setting for various antibody panels which Mayo's neuroimmunology lab offers.   Dr Monteith: That's a nice overlap of subspecialty area. How did you get into this work?   Dr Dubey: I think a lot of it was, sort of, by chance. Meeting the right people at the right time was the main, sort of, motivation for me. Initially, I trained in India for my medical school and didn't really got much exposed to autoimmune neurology in India. I think our primary concern in my training was sort of treating TB meningitis and cerebral malaria - that was my exposure to neurology, including stroke and some epilepsy cases. As a part of application for USMLEs and coming here to residency, I did some externships, and one of the externships was at Memorial Sloan Kettering Cancer Center, and that's when I worked a few weeks with Dr Posner and got introduced to the idea of paraneoplastic neurological syndrome working with him. And that sort of started - I wouldn't call it vicious cycle - but my interest in the area of autoimmune neurology and paraneoplastic neurological disorders, which subsequently was refined further through residency and fellowships.   Dr Monteith: That's interesting. I actually rotated through - I did a externship also at Sloan Kettering, and I had a clinic with Dr Posner. And I thought, at the time, he was such a rock star, and, like, I took a picture with him, and I think he thought it was insane. And I didn't go into autoimmune neurology. So, you know, interesting pathways, right?   Dr Dubey: Yes. And I think he's inspired many, many people, and sort of trained a lot of them as well.   Dr Monteith: So, why don't you tell us what you set out to do when writing this article?   Dr Dubey: So, I think, given my background and training in various subspecialties in neurology, I was, sort of, formally did fellowships in autoimmune neurology, as well as neuromuscular medicine. One of the areas in these areas that I focus on is in my clinical practice, as well as in my sort of lab work, is autoimmune muscular disorders - and that to, specifically, autoantibodies and their clinical utility for autoimmune muscular disorders. So, that's what I wanted to focus on in an article. When I was invited to write an article on autoimmune muscular conditions in general, I thought it was very difficult to pack it all in one chapter or one article, so I narrowed my focus (or tilted my focus) towards antibody-positive disorders and trying to understand how we as neurologists can firstly sort of identify these conditions (which may end up being antibody-positive) – and then, on the other hand, once we get these antibody results, how we can find the utility in them or find them useful in taking care of our patients. At the same time, I also wanted to kind of highlight that these antibodies are not perfect, they do have certain limitations – so, that's another thing I sort of highlighted in the article.   Dr Monteith: So, why don't we just start with a very broad question - what do you believe the role of autoantibodies is in the workup of neuropathies and then neuromuscular disorders? Obviously, when we think of myasthenia gravis, but there are some presentations that you may not necessarily think to first order autoantibody tests. So, what is the role, and where does it fit in the paradigm?   Dr Dubey: I think it's extremely crucial, and it's evolving as time goes on, and it's becoming more and more clinically relevant. Let's say three, four decades ago, the number of biomarkers which were available were very limited and only a handful - and there has been a significant increase in these biomarkers with growing utilization of newer techniques for discovery of antibodies, and more and more people jumping into this field trying to not only discover, but try and understand and validate these biomarkers (what they truly, clinically mean). These antibodies, like you pointed out, ones for myasthenia (such as acetylcholine receptor-binding antibodies, or MuSK antibodies), they can be extremely helpful in clinical diagnosis of these patients. We all know the importance of EMG in managing our patients with neuromuscular disorders. But, oftentimes, EMG nerve conduction studies are often not available at every center. In those scenarios, if you have antibodies with very high clinical specificity, and you're seeing a patient on examination whom you're seeing ptosis (fatigable ptosis), double vision, you're suspecting myasthenia, you send antibodies, and they come back positive. It brings you closer to the answer that may, in turn, require you to refer to a patient to a place where you can get high-quality EMGs or high-quality care. In addition to getting to the diagnosis, it also, sometimes, leads you in directions to search for what is the trigger. A good example is all these paraneoplastic neurological syndromes (which we started our conversation with), where once you find a biomarker (such as anti-Hu antibodies or CRMP5 antibodies) in a patient with paraneoplastic neuropathies, it can direct the search for cancer. These are the patients where, specifically, these two antibodies, small-cell lung cancer is an important cancer to rule out - they require CT scans, and if those are negative, consider doing PET scan – so, we can remove the inciting factor in these cases. And then, lastly, it can guide treatment. Depending upon subtypes of antibodies or particular antibodies, it can give us some idea what is going to be the most effective treatment for these patients.   Dr Monteith: I think paraneoplastic syndromes are a very good example of how autoantibodies can help guide treatment. But, what other examples can you provide for us?   Dr Dubey: Yeah, so I think one of the relatively recent antibody tests which our lab started offering is biomarkers of autoimmune neuropathies - these are neurofascin and contactin, and those are great examples which can target or guide your treatment. I personally, in the past, have had many CIDP patients before we were offering these testings, where we used to kind of start these patients on IVIG. They had the typical electrodiagnostic features, which would qualify them for CIDP. They did not show any response. In many of these cases, we tried to do sort of clinical testing or sort of research-based testing for neurofascin and contactin back in the day, but we didn't have this resource where we can sort of send the blood, hopefully, and within a week, get an answer, whether these patients have autoimmune neuropathy or not. Having this resource now, in some of these cases, even before starting them on IVIG, knowing that test result can guide treatments, such as considering plasma exchange up front as a first-line therapy, followed by rituximab or B-cell depleting therapies, which have been shown to be extremely beneficial in these conditions. And it is not just limited to neurofascin or contactin (which are predominantly IgG4-mediated condition), but the same concept applies to other IgG4-mediated diseases, such as MuSK myasthenia, where having an antibody result can guide your treatment towards B-cell depleting therapies instead of sort of trying the typical regimen that you try for other myasthenia gravis patients.   Dr Monteith: And you mentioned where I was reading that, sometimes, nerve conduction studies and EMG can be useful to then narrow the autoantibody profiles. Oftentimes, in the inpatient service, we order the autoantibodies much faster, because it's sometimes harder to access EMG nerve conduction studies - but talk about that narrowing process.   Dr Dubey: Yeah. And it goes back to the point you just made where we end up sending, sort of, sometimes (and I'm guilty of this as well), where we just send antibodies incessantly, even knowing that this particular patient is not necessarily likely to be an autoimmune neurological disorder, and that can be a challenge, even if the false-positive rate for a particular test is, let's say 1% - if you send enough panels, you will get that false-positive result for a particular patient. And that can have significant effects on the patient - not only unnecessary testing or imaging (depending on what type of antibody it is), but also exposure to various immunotherapies or immunosuppressive therapies. It's important to recognize red flags – and that's one of the things I've focused on in this article, is talking about clinical, as well as electrodiagnostic, factors, which make us think that this might be an autoimmune condition, and then, subsequently, we should consider autoantibody testing. Otherwise, we can be in a situation - that 1% situation - where we may be sort of dealing with a false-positive result, rather than a true-positive result. In terms of EMGs, I think I find them extremely useful, specifically for neuropathies, distinguishing between demyelinating versus exonal, and then catering our antibody-ordering practices toward specific groups of antibodies which are associated with demyelinating neuropathies (if that's what the electrophysiology showed) versus if it's an exonal pathology (considering a different subset of antibodies) - and that's going to be extremely important.   Dr Monteith: You're already getting to my next question, which is what are some of the limitations of autoantibody testing? You mentioned the false-positivity rate - what other limitations are there?   Dr Dubey: So, I think the limitations are both for seropositive, as well as seronegative, patients. As a neurologist, when we see patients and send panels, we can be in a challenging situation in both of those scenarios. Firstly, thinking about seropositives - despite the growing literature about neurology and antibodies, we have to be aware, at least to some extent, about what methodologies are being utilized for these antibody tests. And what I mean by that is knowing when you're sending a sample to a particular lab, the methodology that they're utilizing - is that the most sensitive, specific way to test for certain antibodies? We've learned about this through some of the literature published regarding MOG and aquaporin-4, which has demonstrated that these antibodies, which we suspect are cell surface antibodies, not only generate false-positive, but also false-negative results if they are tested by Western blots or ELISAs. Similar can be applied to some of the cell surface antibodies we are investigating on the autoimmune neuromuscular side (we have some sort of unpublished data regarding that for neurofascin-155). Secondly, it's also kind of critical when you're getting these reports to kind of have a look at what type of secondary antibodies are being utilized, an example being we talked about neurofascin-155, and I mentioned these are IgG4-predominant diseases, so testing for neurofascin IgG4 and knowing that particular patient is positive IgG4 rather than neurofascin pan-IgG. That's an important discrimination, and important information for you to know, because we have seen, at least in my clinical practice, that patients who are positive for neurofascin IgG4 follow the typical story of autoimmune neuropathies - the ones who are not (who are just neurofascin-155 IgG-positive), oftentimes can have wide-ranging phenotypes. The same applies to neurofascin-155 IgMs. And then (not for all antibodies, but for some antibodies), titers are important. A good example of that is a3 ganglionic receptor antibodies, which we utilize for when we're taking care of patients who have autoimmune dysautonomia - and in these cases, if the titers of the antibodies are below .2 nmol/L, usually, those don't have a high specificity for AAG diagnosis. So, I get referred a lot of patients with very low titers of a3 ganglionic receptor antibodies, where the clinical picture does not at all look like autoimmune autonomic ganglionopathy. So, that's another thing to potentially keep in mind. And then, on the seronegative front, it's important to recognize that we are still sort of seeing the tip of the iceberg as far as these antibodies or biomarkers are concerned, specifically for certain phenotypes, such as CIDP. If you look at the literature, depending upon what demographics we're looking at or sort of racial profiles we're looking at, the frequency of these autoimmune neuropathy biomarkers range from 5% to 20%, with much higher frequency in Asian patients - so, a good chunk of these diseases are still seronegative. In the scenario where you have a very high suspicion for an autoimmune neuromuscular disorder (specifically, we'll talk about neuropathies, because that's why we utilize tissue immunofluorescence staining on neural tissues), I recommend people to potentially touch base with that tertiary care lab or that referral lab to see if they have come across some research-based antibodies which are not clinically validated, which can give you some idea, some additional supportive idea, that what you're dealing with is an autoimmune neuromuscular disorder. So, we have to keep the limitations of some of these antibody panels and antibody tests in mind for both positive, as well as negative, results.   Dr Monteith: So, you've already given us a lot of good stuff, um, about titer seronegativity and false-positive rates. And, you know, also looking at the clinical picture when ordering these tests, utilizing EMG nerve conduction studies, give us a major key point that we can't not get when reading your article.   Dr Dubey: I think the major key point is we are neurologists first and serologists later. Most of these patients, we have to kind of evaluate them clinically and convince ourselves at least partly that this might be an autoimmune neuromuscular disorder before sending off these panels. Also, I find it useful to narrow down the phenotype, let's say, in a particular neuropathy or a muscle disease or a hyperexcitability syndrome. So, I have a core group of antigens, autoantigens, or autoantibodies, which I'm expecting and making myself aware of - things beyond that will raise my antenna - potentially, is this truly relevant? Could this be potentially false-positive? So, clinical characterization up front, phenotypic characterization upfront, and then utilizing those antibody results to support our clinical decision-making and therapeutic decision-making is what I've tried to express in this article.   Dr Monteith: And what is something that you wish you knew much earlier in your career?   Dr Dubey: It's a very challenging field, and it's a rapidly evolving field where we learn many things nearly every year, and, sometimes, we learn things that were previously said were incorrect, and we need to kind of work on them. A good example of that is initial reports of voltage-gated potassium-channel antibodies. So, back in the day when I was actually in my medical school and (subsequently) in my residency, voltage-gated potassium-channel antibodies were closely associated with autoimmune neuromyotonia, or autoimmune peripheral hyperexcitability syndromes. Now, over time, we've recognized that only the patients who are positive for LGI1 or CASPR2 are the ones who truly have autoimmune neuromuscular disorders or even CNS disorders. The voltage-gated potassium-channel antibody by itself, without LGI1 or CASPR2, truly doesn't have a very high specificity for neurological autoimmunity. So, that's one example of how even things which were published were considered critical thinking or critical knowledge in our field of autoimmune neuromuscular disorders has evolved and has sort of changed over time. And, again, the new antibodies are another area where nearly every year, something new pops up - not everything truly stands a test of time, but this keeps us on our toes.   Dr Monteith: And what's something that a patient taught you?   Dr Dubey: I think one of the things with every patient interaction I recognize is being an autoimmune neurologist, we tend to focus a lot on firstly, diagnosis, and secondly, immunotherapy - but what I've realized is symptomatic and functional care beyond immunotherapy in these patients who have autoimmune neurological disorders is as important, if not more important. That includes care of patients, involving our colleagues from physical medicine and rehab in terms of exercise regimen for these patients as we do immunotherapies, potentially getting a plan for management of associated pain, and many other factors and many other symptoms that these patients have to deal with secondary to these autoimmune neurological conditions.   Dr Monteith: I think that's really well said, because we get excited about getting the diagnosis and then getting the treatment, but that long-term trajectory and quality of life is really what patients are seeking.   Dr Dubey: Yeah, and as you pointed out, most of the time, especially when we are in inpatient service, or even when we're seeing the patients upfront outpatient, we are seeing them, sometimes, in their acute phase or at their disease not there. What we also have to realize is, what are the implications of these autoimmune neurological conditions in the long term or five years down the line? And that's one of the questions patients often ask me and how this can impact them even when the active immune phase has subsided - and that's something we are actively trying to learn about.   Dr Monteith: So, tell me something you're really excited about in your field.   Dr Dubey: I think, firstly (which is pretty much the topic of my entire article), is novel antibodies and new biomarker discoveries. That's very exciting - we are actively, ourselves, involved in the space. The second thing is better mechanistic understanding of how these antibodies cause diseases, so we can not only understand diseases, we can also try and understand how to target and treat these diseases - this is being actively done for various disorders. One of the disorders which continue to remain a challenge are T-cell mediated diseases, where these antibodies are just red flags or biomarkers are not causing the disease, but it's potentially the T-cells possibly attacking the same antigen which are causing disease process, and those are often the more refractory and harder-to-treat conditions. I'm hoping that with some of the work done in other fields (such as rheumatology or endocrinology for type one diabetes), we're able to learn and apply the same in the field of autoimmune neurology and autoimmune neuromuscular medicine. And then, the final frontier is developing therapies which are antigen specific, where you have discovered that somebody has a particular antibody, and if that antibody is pathogenic, can I just deplete that antibody, not necessarily pan-depleting the immune system. And there is some translational data, there's some animal model data in that area, which I find very exciting, will be extremely helpful for many of my patients.   Dr Monteith: So, very personalized targeted therapies?   Dr Dubey: Correct. Without having all the side effects we all have to kind of take care of in our patients when we start them on, let's say, cyclophosphamide, or some of these really, really, significantly suppressive immunosuppressive medications.   Dr Monteith: Well, thank you so much. I learned a lot from reading your article to prepare for this interview, but also just from talking to you. And it's clear that you're very passionate about what you do and very knowledgeable as well, so, thank you so much.   Dr Dubey: Thank you so much. Thank you for inviting me to do this. And thank you for inviting me to contribute the article.   Dr Monteith: Today, I've been interviewing Dr Divyanshu Dubey, whose article on autoimmune neuromuscular disorders associated with neural autoantibodies appears in the most recent issue of Continuum on autoimmune neurology. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining us today.   Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information, important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at Continpub.com/AudioCME. Thank you for listening to Continuum Audio.

Bonus Episode!  Greg Stanley reviews the action and some favorite cars with Steven Posner from Putnam Leasing during RM Sotheby's auction during Monterey Car Week.  You can lease your dream car at www.PutnamLeasing.com. Please support our sponsors: www.RMSothebys.com, www.LLCTLC.com and www.EuroClassix.com. For discounted registration fees for your collector car, RV, boat or other awesome ride, please visit LLCTLC at https://www.llctlc.com/classic Follow The Collector Car Podcast: Website, Instagram, Facebook, YouTube or communicate with Greg directly via Email. Join RM Sotheby's Car Specialist Greg Stanley as he applies over 25 years of insight and analytical experience to the collector car market. Greg interviews the experts, reviews market trends and even has some fun. Podcasts are posted every Thursday and available on Apple Podcast, GooglePlay, Spotify and wherever podcasts are found. See more at www.TheCollectorCarPodcast.com or contact Greg directly at Greg@TheCollectorCarPodcast.com. Are you looking to consign at one of RM Sotheby's auctions? Email Greg at GStanley@RMSothebys.com.

Discover the Unexpected Power of Self-Expression with Sean Kelly on the Digital Social Hour!

As freelancers and solo professionals, we often (unknowingly) sabotage our own success from the very first interaction with a prospect.   We present ourselves and our services in a way that works against us. It erodes trust and diminishes our perceived value before we even begin working with a potential client.   It often starts the moment we ask our clients, "What can I do for you?"   This simple question can unknowingly shift us from being experts in our field to mere order-takers, losing control of our own business direction.   From there, it shows up in what we say to clients and prospects. What we offer. How we price our work. How we position ourselves in the market. And how we talk about what we do and the value we deliver.   In this episode, we're diving deep into this critical issue. My guest is , an experienced freelance professional and entrepreneur who has mastered the art of positioning herself as an expert rather than an order-taker.   Amy shares invaluable insights on how to regain control of your freelance business, build authority with clients, and establish yourself as the go-to expert in your field.   We explore a number of important topics, including:   Recognizing when you've fallen into the order-taker role and how to break free Practical steps to shift from order-taker to expert (and yes, you ARE more of an expert than you realize!) Building and demonstrating authority—even if you're shy or introverted Setting boundaries and managing client expectations Developing the communication skills and confidence needed to position yourself as an expert   Whether you're a seasoned freelancer looking to level up your business or still in the early stages of growing your practice, this episode offers valuable insights to help you take back the power in your business and truly thrive as a freelance professional.   I hope you find our conversation enlightening and actionable!

To get live links to the music we play and resources we offer, visit www.WOSPodcast.comThis show includes the following songs:Paige Christine - Jerome FOLLOW ON SPOTIFYEmmeleine - Goodbye To You FOLLOW ON SPOTIFYWild Remedy - Little Me FOLLOW ON SPOTIFYTess Posner - Ghosts FOLLOW ON SPOTIFYPhoebe Blume - Listen to the Knockin FOLLOW ON SPOTIFYSanjna - Table For Two FOLLOW ON SPOTIFYElsie Binx - It's Your Decision FOLLOW ON SPOTIFYDanielle Schroeder - Redwing Blackbird FOLLOW ON SPOTIFYManisha Shahane - Still FOLLOW ON SPOTIFYSandra Palmer - Any Time Now (Just Not Tonight) FOLLOW ON SPOTIFYFor Music Biz Resources Visit www.FEMusician.com and www.ProfitableMusician.comVisit our Sponsor Sanjna at sanjnamusic.comVisit our Sponsor Sarah Lucie at sarahlucie.comVisit our Sponsor Track Stage at https://profitablemusician.com/trackstageVisit our Sponsor Your Guitar Sage at https://profitablemusician.com/guitarVisit www.wosradio.com for more details and to submit music to our review board for consideration.Visit our resources for Indie Artists: https://www.wosradio.com/resources

Episode 2510 - On this Friday's show Vinnie Tortorich speaks with barefoot runner Ken Posner about running over twelve thousand miles, mindfulness in nature, and more. https://vinnietortorich.com/2024/07/twelve-thousand-miles-ken-posner-episode-2510 PLEASE SUPPORT OUR SPONSORS YOU CAN WATCH ALL THE PODCAST EPISODES ON YOUTUBE - Twelve Thousand Miles Barefoot running is a trend that has slowed down, but not for Ken. (2:00) An hour of cardio per day is recommended for good cardiac health. (8:00) Sitting is the new smoking. We get used to setting a new normal for ourselves that is so comfortable, we move further away from what our bodies were meant to do (10:30) Ken describes his transition to barefoot running (15:00) There are difficulties to it that people need help getting used to, but Ken loves it. Ken has logged approximately 12,000 miles running barefoot! (22:30) He used to wear orthotics but his feet have changed due to barefoot running. Our feet aren't meant to wear shoes with heels or run in shoes with too much cushion. They swap stories about certain popular processed foods and how our brains adjust to them (or not). (37:00) Vinnie asks about injuries. (47:00) They discuss the challenges along the John Muir Trail. Getting out in nature reconnects us to being mindful. (55:00) Ken has a personal goal of climbing a thousand mountains. You can follow Ken on his website and blog:  There's a new NSNG® Foods promo code you can use: enter VINNIE and get 15% off! (25:00) The promo code ONLY works on the NSNG® Foods website, NOT on Amazon. Vinnie's new documentary "Dirty Keto" is out soon! Go to to get it at ! [the_ad id="20253"] PURCHASE BEYOND IMPOSSIBLE (2022) The documentary launched on January 11! Order it TODAY! This is Vinnie's third documentary in just over three years. Get it now on Apple TV (iTunes) and/or Amazon Video! Link to the film on Apple TV (iTunes):  Then, Share this link with friends, too! It's also now available on Amazon (the USA only for now)!  Visit my new Documentaries HQ to find my films everywhere: REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter!  

From June 29, 2020: Jack Goldsmith sat down with Eric Posner, the Kirkland & Ellis Distinguished Service Professor of Law at the University of Chicago, and the author of the new book, "The Demagogue's Playbook: The Battle for American Democracy from the Founders to Trump." They discussed why demagogues are a characteristic threat in democracies, how the founders of the U.S. Constitution tried to ensure elite control and prevent a demagogue from becoming president, how these safeguards weakened over time and how Donald Trump's demagoguery helped him win election as president. They also explored how Posner's perception of Trump as a threat to American democracy fits with his writings in support of a powerful president.To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/c/trumptrials.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

#702: Today we're sitting down with Mike Posner. Mike Posner's expansive, multi-platinum discography has earned him global recognition, and in 2019, Posner walked nearly 3,000 miles across North America in an effort to inspire people to challenge themselves, surviving a rattlesnake bite along the way. He then made it to the peak of Mount Everest in 2021, raising more than $250,000 for the Detroit Justice Center for his endeavor. Today, we discuss his career, how he got a record deal from Jay Z, and the thought behind his hit song, "I Took A Pill In Ibiza." He also discusses his journey with his mental health, finding solitude, walking across the USA, and climbing Mt. Everest. To connect with Mike Posner click HERE To connect with Lauryn Bosstick click HERE To connect with Michael Bosstick click HERE Read More on The Skinny Confidential HERE To Watch the Show click HERE For Detailed Show Notes visit TSCPODCAST.COM To Call the Him & Her Hotline call: 1-833-SKINNYS (754-6697) This episode is brought to you by The Skinny Confidential This episode is brought to you by Airsculpt Get $1000 off an Airsculpt procedure when you complete a consultation. Visit airsculpt.com/skinny to find out more. This episode is brought to you by Betterhelp BetterHelp is online therapy that offers video, phone, and even live chat-only therapy sessions. So you don't have to see anyone on camera if you don't want to. It's much more affordable than in-person therapy & you can be matched with a therapist in under 48 hours. Our listeners get 10% off their first month at betterhelp.com/skinny. This episode is brought to you by ServPro SERVPRO is the #1 choice in cleanup and restoration. Visit SERVPRO.com or call 1-800-SERVPRO today. This episode is brought to you by Just Thrive These days, stress seems to hit us from every possible angle in any environment at any time, day after day. Enter Just Calm - the breakthrough new stress and mood support formula from Just Thrive. Get 20% off a 90-day bottle of Just Thrive probiotic + Just Calm supplement at justthrivehealth.com with code SKINNY at checkout. This episode is brought to you by Squarespace From websites and online stores to marketing tools and analytics, Squarespace is the all-in-one platform to build a beautiful online presence and run your business. Go to squarespace.com/skinny for a free trial & use code SKINNY for 10% off your first purchase of a website domain. This episode is brought to you by OneSkin Get 15% Off OneSkin products by using code SKINNY at oneskin.co Produced by Dear Media